Published in Am J Respir Crit Care Med on December 01, 1999
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax (2006) 4.04
Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med (2006) 3.71
Pulmonary rehabilitation. Thorax (2001) 2.63
Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax (2006) 2.55
Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20
Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung (2008) 1.92
Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med (2014) 1.77
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung (2010) 1.65
Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax (2005) 1.58
Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol (2012) 1.49
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD. Prim Care Respir J (2012) 1.45
Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One (2012) 1.44
Obesity paradox does exist. Diabetes Care (2013) 1.40
Altered respiratory physiology in obesity. Can Respir J (2006) 1.35
Body composition and functional limitation in COPD. Respir Res (2007) 1.35
The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle (2012) 1.35
The genetics of chronic obstructive pulmonary disease. Respir Res (2001) 1.33
Obesity, adipokines, and lung disease. J Appl Physiol (1985) (2009) 1.30
Obesity paradox: conditioning on disease enhances biases in estimating the mortality risks of obesity. Epidemiology (2014) 1.24
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.24
Hepcidin: A useful marker in chronic obstructive pulmonary disease. Ann Thorac Med (2012) 1.24
Predictors of mortality in alpha1-antitrypsin deficiency. Thorax (2003) 1.24
Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle (2011) 1.22
Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med (2007) 1.18
Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res (2011) 1.13
The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol (2014) 1.10
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res (2007) 1.10
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol (2012) 1.09
Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD (2011) 1.06
Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med (2009) 1.06
The aging lung. Clin Interv Aging (2013) 1.05
Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol. Int J Chron Obstruct Pulmon Dis (2012) 1.03
Chronic obstructive pulmonary disease. Indian J Med Res (2013) 1.02
Predictors of mortality in patients with stable COPD. J Gen Intern Med (2008) 1.01
Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis (2015) 0.99
The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis (2009) 0.98
Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes. Med Clin North Am (2012) 0.98
Vitamin D status and cause-specific mortality: a general population study. PLoS One (2012) 0.98
The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med (2010) 0.97
Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD. Lung (2011) 0.96
Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score. Ann Epidemiol (2010) 0.95
Influence of diet and obesity on COPD development and outcomes. Int J Chron Obstruct Pulmon Dis (2014) 0.93
Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo) (2010) 0.93
A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem. J Community Hosp Intern Med Perspect (2012) 0.93
Changes in blood hemoglobin and blood gases PaO2 and PaCO2 in severe COPD overa three-year telemonitored program of long-term oxygen treatment. Multidiscip Respir Med (2012) 0.93
The Saudi Guidelines for the Diagnosis and Management of COPD. Ann Thorac Med (2014) 0.92
Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat. Indian J Endocrinol Metab (2014) 0.92
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. Int J Chron Obstruct Pulmon Dis (2009) 0.91
Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis (2015) 0.91
Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD). Nutrients (2013) 0.91
Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 0.90
Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med (2010) 0.90
Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis (2012) 0.90
A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.90
Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene. Curr Opin Clin Nutr Metab Care (2008) 0.90
Heart rate variability and disease characteristics in patients with COPD. Lung (2008) 0.90
Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality--results from a 10-year prospective cohort study. PLoS One (2013) 0.90
Obesity and physical activity in the daily life of patients with COPD. Lung (2012) 0.90
Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J (2012) 0.89
Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm (2010) 0.88
Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis (2014) 0.88
Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease. Metabolism (2011) 0.87
New considerations on hormetic response against oxidative stress. J Cell Commun Signal (2014) 0.87
Use of the Breathlessness, Cough, and Sputum Scale (BCSS(©)) in Pulmonary Rehabilitation. Open Respir Med J (2013) 0.87
Relationship of BODE Index to functional tests in chronic obstructive pulmonary disease. Clinics (Sao Paulo) (2009) 0.86
Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 0.86
Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med (2015) 0.86
Impact of visceral adiposity measured by abdominal computed tomography on pulmonary function. J Korean Med Sci (2011) 0.86
Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS). J Cachexia Sarcopenia Muscle (2013) 0.86
Defining disease modification in chronic obstructive pulmonary disease. COPD (2009) 0.85
Respiratory Consequences of Mild-to-Moderate Obesity: Impact on Exercise Performance in Health and in Chronic Obstructive Pulmonary Disease. Pulm Med (2012) 0.85
Predictors' factors of nutritional status of male chronic obstructive pulmonary disease patients. ISRN Nurs (2012) 0.84
Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial. Int J Chron Obstruct Pulmon Dis (2008) 0.84
Interleukin-10 -592C/A, -819C/T and -1082A/G Polymorphisms with Risk of Type 2 Diabetes Mellitus: A HuGE Review and Meta-analysis. PLoS One (2013) 0.84
BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice? BMC Med (2010) 0.84
Evaluation of psychological and physiological predictors of fatigue in patients with COPD. BMC Pulm Med (2009) 0.83
Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int (2014) 0.83
Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One (2014) 0.83
High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1). J Biol Chem (2015) 0.83
Integrative genomics of chronic obstructive pulmonary disease. Biochem Biophys Res Commun (2014) 0.82
Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD. Int J Chron Obstruct Pulmon Dis (2011) 0.82
Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients. PLoS One (2013) 0.82
Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study. J Inflamm (Lond) (2015) 0.82
Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients. Multidiscip Respir Med (2010) 0.81
Association between body mass index and in-hospital outcomes: Analysis of the nationwide inpatient database. Medicine (Baltimore) (2016) 0.81
More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation? Ann Behav Med (2009) 0.81
Determinants of health related quality of life in a sample of patients with chronic obstructive pulmonary disease in Nigeria using the St. George's respiratory questionnaire. Afr Health Sci (2013) 0.81
Plasma orexin-a levels in COPD patients with hypercapnic respiratory failure. Mediators Inflamm (2011) 0.81
The relationships of serum prealbumin levels with parameters that indicate severity of disease and emphysema pattern in patients with stable chronic obstructive pulmonary disease. Eurasian J Med (2010) 0.81
Correlation of BMI and oxygen saturation in stable COPD in Northern India. Lung India (2014) 0.81
Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena. COPD (2008) 0.80
Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment. BMC Pulm Med (2013) 0.80
Systemic inflammation and progression of COPD. Thorax (2007) 0.80
Biomarkers in chronic obstructive pulmonary disease: confusing or useful? Int J Chron Obstruct Pulmon Dis (2014) 0.80
Obesity is Associated with Increased Morbidity in Moderate to Severe COPD. Chest (2016) 0.79
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet (1998) 4.53
A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med (1998) 4.52
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax (2006) 4.04
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (1999) 3.90
Developing COPD: a 25 year follow up study of the general population. Thorax (2006) 3.72
Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ (1998) 3.45
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited. Eur Respir J (2008) 3.36
Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J (1997) 3.29
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J (2002) 3.22
Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med (1996) 3.14
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem (1991) 2.52
Epidemiology of chronic obstructive pulmonary disease. Eur Respir J (2001) 2.43
Gene duplication in Saccharomyces cerevisiae. Genetics (1978) 2.41
Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tob Control (1998) 2.13
Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. J Epidemiol Community Health (2003) 2.13
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J (2009) 2.11
Mortality in joggers: population based study of 4,658 men. BMJ (2000) 2.10
COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J (2008) 2.06
Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. Am Heart J (1995) 1.92
Recommendations for epidemiological studies on COPD. Eur Respir J (2011) 1.84
Life expectancy in Danish women and men related to smoking habits: smoking may affect women more. J Epidemiol Community Health (1998) 1.80
Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol (2001) 1.79
Gender and determinants of smoking cessation: a longitudinal study. Prev Med (1999) 1.79
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.78
The natural history of chronic obstructive pulmonary disease. Eur Respir J (2006) 1.66
Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax (1997) 1.62
Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J (2002) 1.60
Socioeconomic status and chronic obstructive pulmonary disease. Thorax (1999) 1.60
Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax (2002) 1.59
Importance of characteristics and modalities of physical activity and exercise in defining the benefits to cardiovascular health within the general population: recommendations from the EACPR (Part I). Eur J Prev Cardiol (2012) 1.57
Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J (1999) 1.56
The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease. Respir Med (1992) 1.54
Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J (1995) 1.52
Mortality in women and men in relation to smoking. Int J Epidemiol (1998) 1.52
Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochemistry (1980) 1.52
Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J (2011) 1.47
NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park) (1996) 1.46
Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax (2010) 1.46
BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy. Chron Respir Dis (2004) 1.44
[Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger (1998) 1.42
Potential misclassification of causes of death from COPD. Eur Respir J (2006) 1.42
Perceived stress as a risk factor for changes in health behaviour and cardiac risk profile: a longitudinal study. J Intern Med (2009) 1.41
Tracheobronchomalacia: dynamic airway evaluation with multidetector CT. AJR Am J Roentgenol (2001) 1.40
[Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease]. Ugeskr Laeger (1996) 1.39
Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv (2001) 1.39
Trends in smoking prevalence in Danish adults, 1964-1994. The influence of gender, age, and education. Scand J Soc Med (1998) 1.36
Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax (2008) 1.34
Stress and life dissatisfaction are inversely associated with jogging and other types of physical activity in leisure time--The Copenhagen City Heart Study. Scand J Med Sci Sports (2005) 1.28
Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J (2003) 1.28
Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med (1994) 1.27
Social position and mortality from respiratory diseases in males and females. Eur Respir J (2003) 1.26
Spontaneous pneumothorax: comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis. Thorax (1989) 1.26
Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol (2005) 1.24
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J (2010) 1.23
Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med (2008) 1.17
Community medicine clerkships in an applied research setting. J Med Educ (1977) 1.17
NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) (1998) 1.16
High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol (1999) 1.15
Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology (1998) 1.15
Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet (1996) 1.14
Rehabilitation of patients with chronic obstructive pulmonary disease. Exercise twice a week is not sufficient! Respir Med (2000) 1.13
Accuracy of recorded asthma deaths in Denmark in a 12-months period in 1994/95. Respir Med (2000) 1.13
Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients. Blood (1998) 1.13
A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course. Cancer (1979) 1.12
Predictors of smoking reduction and cessation in a cohort of danish moderate and heavy smokers. Prev Med (2001) 1.12
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J (2005) 1.10
Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax (2006) 1.10
Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung (2007) 1.09
Genetic Load and Viability Distribution in Central and Marginal Populations of DROSOPHILA SUBOBSCURA. Genetics (1977) 1.09
The International Journal of Tuberculosis and Lung Disease--a home for respiratory epidemiology. Int J Tuberc Lung Dis (1998) 1.08
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol (1996) 1.07
[House dust mite allergens and mite allergy in Copenhagen dwellings. A cross-sectional study]. Ugeskr Laeger (1999) 1.07
Promoter trapping of a novel medium-chain acyl-CoA oxidase, which is induced transcriptionally during Arabidopsis seed germination. J Biol Chem (2000) 1.06
Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.06
Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J (1995) 1.05
Perceived stress and risk of adult-onset asthma and other atopic disorders: a longitudinal cohort study. Allergy (2012) 1.05